Justine Habault

Years Active: 2018-2023
Publications (10 Years): 5

Inserm U976

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Inserm U976 Sep 01 2016 - Jun 15 2020

France

PhD Candidate

Publications

Justine Habault, Jeffrey A Schneider, Susan Ha, Rachel Ruoff, Luiza D Doro Pereira, Joseph Puccini, Michela Ranieri, Ruveyda Ayasun, Jiehui Deng, Amanda C Kasper, Dafna Bar-Sagi, Kwok-Kin Wong, Amina Zoubeidi, Frank Claessens, David R Wise, Susan K Logan, Kent Kirshenbaum, Michael J Garabedian
A multivalent peptoid conjugate modulates androgen receptor transcriptional activity to inhibit therapy-resistant prostate cancer. Molecular cancer therapeutics (2023)
Prashanth Thevkar-Nagesh, Justine Habault, Maud Voisin, Sophie E Ruff, Susan Ha, Rachel Ruoff, Xi Chen, Shruti Rawal, Tarik Zahr, Gyongyi Szabo, Inez Rogatsky, Edward A Fisher, Michael J Garabedian
Transcriptional regulation of Acsl1 by CHREBP and NF-kappa B in macrophages during hyperglycemia and inflammation. PloS one 17 (9) (2022)
Justine Habault, Nicolas Thonnart, Caroline Ram-Wolff, Martine Bagot, Armand Bensussan, Jean-Luc Poyet, Anne Marie-Cardine
Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model. Cells 11 (19) (2022)
Justine Habault, Jean-Luc Poyet
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies. Molecules (Basel, Switzerland) 24 (5) (2019)
Ewa Pasquereau-Kotula, Justine Habault, Guido Kroemer, Jean-Luc Poyet
The anticancer peptide RT53 induces immunogenic cell death. PloS one 13 (8) (2018)

Justine Habault.css-eqlu8i{font-size:small;padding-left:4px;}